Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the Companys ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study
R., Hunt, P
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
Keep a symptom diary to distinguish medication side effects from potential kidney problems, and maintain open communication with your healthcare team
Like many clinicians, I initially thought about these drugs mostly in terms of weight loss and metabolic disease
The good news: GLP-1 naturally suppresses appetite during travel, making it easier to avoid airport junk food